Tissue-engineered 3D cancer-in-bone modeling: silk and PUR protocols

Area of Science:

• Oncology
• Biomedical Engineering
• Cell Biology

Background:

• Bone marrow cancers are often incurable and cause significant bone damage.
• Current two-dimensional (2D) pre-clinical models inadequately predict drug efficacy, leading to clinical trial failures.
• The bone microenvironment is a complex, dynamic, three-dimensional (3D) system influencing tumor growth and disease progression.

Purpose of the Study:

• To review available 3D culture models for studying tumor-induced bone disease.
• To highlight the advantages of 3D models over 2D models in pre-clinical research.
• To provide protocols for established 3D culture systems.

Main Methods:

• Review of existing literature on 3D culture models for bone metastasis research.
• Detailed description of protocols for two prominent 3D bone disease models.
• Comparison of 3D co-culture systems with traditional 2D mono-cultures.

Main Results:

• 3D co-culture systems more accurately model *in vivo* cell phenotypes, disease progression, and therapeutic responses compared to 2D models.
• 3D models facilitate better understanding of cell-cell and cell-matrix interactions within the bone microenvironment.
• The use of 3D models can enhance the predictive power of pre-clinical studies for cancer therapeutics.

Conclusions:

• Three-dimensional (3D) culture systems offer a superior platform for studying tumor-induced bone disease.
• Adoption of 3D models can improve the translation of pre-clinical findings to clinical success.
• Protocols for established 3D models can aid researchers in developing more effective cancer treatments.